MKI67 and neoplasm: Tumor cellular proliferation was observed by staining for Ki67 (Fig. 5h), and the results further confirmed that the treatment exerted synergetic immunomodulation, CDT, and hypoxia-activated chemotherapy with an amplified antitumor efficacy.